Michael A. Narachi's Insider Trades & SAST Disclosures

Michael A. Narachi's most recent trade in Ultragenyx Pharmaceutical Inc. was a trade of 10,787 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 15, 2025.

Share

Note

This is a custom search result for pattern Michael A. Narachi.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Ultragenyx Pharmaceutical ... 10-year low	Michael A. Narachi	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 May 2025	10,787	10,787	-		-	Stock Option (Right to Buy)
Ultragenyx Pharmaceutical ... 10-year low	Michael A. Narachi	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 May 2025	5,740	32,690 (0%)	0%		0	Common Stock
Ultragenyx Pharmaceutical ... 10-year low	Michael A. Narachi	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Jun 2024	9,900	9,900	-		-	Stock Option (Right to Buy)
Ultragenyx Pharmaceutical ... 10-year low	Michael A. Narachi	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Jun 2024	5,345	26,950 (0%)	0%		0	Common Stock
Ultragenyx Pharmaceutical ... 10-year low	Michael A. Narachi	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Jun 2023	7,110	7,110	-		-	Common Stock
Ultragenyx Pharmaceutical ... 10-year low	Michael A. Narachi	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Jun 2023	3,860	21,605 (0%)	0%		0	Common Stock
Ultragenyx Pharmaceutical ... 10-year low	Michael A. Narachi	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2022	6,245	6,245	-		-	Stock Option (Right to Buy)
Ultragenyx Pharmaceutical ... 10-year low	Michael A. Narachi	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2022	3,300	17,745 (0%)	0%		0	Common Stock
Ultragenyx Pharmaceutical ... 10-year low	Michael A. Narachi	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2021	4,125	4,125	-		-	Stock Option (Right to Buy)
Ultragenyx Pharmaceutical ... 10-year low	Michael A. Narachi	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2021	2,145	14,445 (0%)	0%		0	Common Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades